Amanda J. Cork
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
An mRNA vaccine encoding five conserved Group A Streptococcus antigens.
Journal: Nature communications
Published: January 17, 2025
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Streptococcus Pharyngeal Infection in a Non-Human Primate Model.
Journal: Vaccines
Published: March 01, 2024
Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria.
Journal: Nature communications
Published: February 01, 2023
Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA.
Journal: Nature communications
Published: September 21, 2022
Streptococcus pyogenes Hijacks Host Glutathione for Growth and Innate Immune Evasion.
Journal: mBio
Published: April 25, 2022
Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria.
Journal: Antibiotics (Basel, Switzerland)
Published: February 07, 2022
Streptolysins are the primary inflammasome activators in macrophages during Streptococcus pyogenes infection.
Journal: Immunology and cell biology
Published: June 22, 2021
Erratum for Rivera-Hernandez et al., "An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model".
Journal: mBio
Published: December 02, 2020
A multivalent T-antigen-based vaccine for Group A Streptococcus.
Journal: Scientific reports
Published: October 06, 2020
Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies.
Journal: mBio
Published: March 12, 2020
Last Updated: 09/26/2026